Rapport Therapeutics, Inc. (RAPP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2023: -$27.18M2024: -$64.83M2025: -$87.47M-$87.47M
2023Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$87.47M-34.9%
2024-$64.83M-138.5%
2023-$27.18M